# Rich Pharmaceuticals, Inc.

Rich Pharmaceuticals, Inc. is a company headquartered in Los Angeles, CA, United States.

## Company overview

- **Legal name:** Rich Pharmaceuticals, Inc.
- **Former names in filing history:** Nepia Inc. (2011-04-25 to 2013-08-19)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Los Angeles, CA, United States
- **Incorporated in:** WY
- **Fiscal year end:** March 31
- **SEC CIK:** 0001504389

## About

Rich Pharmaceuticals, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001504389, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2018-07-17, it reported annual revenue of USD 115,000; net income of USD -1,692,341; total assets of USD 37,429 for the fiscal period ended 2018-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-03-31)

- **Revenue:** $115,000 (USD 115,000)
- **Net income:** -$1.7M (USD -1,692,341)
- **Total assets:** $37,429 (USD 37,429)
- **Cash and equivalents:** $6,222 (USD 6,222)
- **Operating cash flow:** -$508,479 (USD -508,479)

### FY2017 (period ended 2017-03-31)

- **Net income:** -$3.2M (USD -3,241,329)
- **Total assets:** $53,028 (USD 53,028)
- **Cash and equivalents:** $40,903 (USD 40,903)
- **Operating cash flow:** -$553,394 (USD -553,394)

### FY2016 (period ended 2016-03-31)

- **Net income:** -$1.8M (USD -1,768,460)
- **Total assets:** $6,531 (USD 6,531)
- **Operating cash flow:** -$495,099 (USD -495,099)

### FY2015 (period ended 2015-03-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$4.1M (USD -4,133,576)
- **Total assets:** $24,258 (USD 24,258)
- **Cash and equivalents:** $15,892 (USD 15,892)
- **Operating cash flow:** -$1.4M (USD -1,445,068)

## Recent SEC filings

- Form 8-K — filed 2021-07-06 — period 2021-07-01 — 8-K
- Form 8-K — filed 2019-07-03 — period 2019-06-11 — 8-K
- Form 8-K — filed 2019-02-12 — period 2019-02-12 — 8-K
- Form 10-K — filed 2018-07-17 — period 2018-03-31 — 10-K
- Form 8-K — filed 2018-04-13 — period 2018-04-10 — 8-K
- Form 8-K — filed 2018-03-23 — period 2018-03-15 — 8-K
- Form 8-K — filed 2018-03-12 — period 2018-03-02 — 8-K
- Form 8-K — filed 2018-02-26 — period 2018-02-09 — 8-K
- Form 10-Q — filed 2018-02-20 — period 2017-12-31 — 10-Q
- Form 8-K — filed 2018-02-06 — period 2018-02-01 — 8-K
- Form S-1 — filed 2018-01-24 — S-1
- Form 8-K — filed 2018-01-23 — period 2018-01-18 — 8-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/rich-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology